Burningtiger, the last quote in your post, 'hesitant of the road you see ahead', let me correct the misunderstanding, ADMEDUS is a global company that has put an international management team in place to rival any Bio/Pharma company in their field with Professor Ian Frazer, the king of immunotherapies in his field and Professor Leon Neethling with a breakthrough technology in tissue.
WP is the master of reorganisation on a global scale, he has taken ADMEDUS from a start-up to a global heavyweight. I say this because not only do I see the difference in AHZ's management but also what is happening in the global management meaning vasculcel has opened up for ADMEDUS on the grounds that Baxter is out, I can't see surgeons using anything else.
When the 3D Curved Patch comes out it will be a first with no opposition. Now, this is fact and ADMEDUS is ready to take over these markets so please be patient till the end of FY17.
So, mate, I hope this helps and we will pick up our conversation about WP's salary in just over 2 months so I have the proof before I start talking about it.
- Forums
- ASX - By Stock
- AVR
- Ann: Response to Aware Query
Ann: Response to Aware Query, page-78
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.91 |
Change
-0.090(0.90%) |
Mkt cap ! $209.4M |
Open | High | Low | Value | Volume |
$10.00 | $10.00 | $9.65 | $70.76K | 7.202K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 300 | $9.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.91 | 475 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 300 | 9.800 |
1 | 200 | 9.600 |
1 | 2 | 9.540 |
1 | 330 | 9.510 |
2 | 1185 | 9.500 |
Price($) | Vol. | No. |
---|---|---|
9.910 | 475 | 2 |
9.990 | 99 | 1 |
10.000 | 250 | 1 |
10.500 | 10005 | 2 |
11.000 | 5000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online